COMMUNIQUÉS West-GlobeNewswire

-
Fennec Pharmaceuticals Initiates Rolling New Drug Application to U.s. Food and Drug Administration for PEDMARK™
20/12/2018 -
Genmab Announces European Commission Approval of DARZALEX® (daratumumab) Split Dosing Regimen
20/12/2018 -
Herb Names Maverick Technology Solutions’ ROSINBOMB™ Rocket the Best Portable Rosin Press
20/12/2018 -
RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®
20/12/2018 -
RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®
20/12/2018 -
Chi-Med Announces Progress in Savolitinib Lung Cancer Program and Update on Kidney Cancer Strategy
20/12/2018 -
Chi-Med Announces Amendment to the 2013 License & Collaboration Agreement on Fruquintinib with Eli Lilly and Company
20/12/2018 -
Rule 2.9 Announcement
20/12/2018 -
AroCell signs distribution agreement with Eurobio Scientific in France
20/12/2018 -
PCI Biotech: Preliminary confirmation of safety read-out from the fimaChem Phase I extension study in bile duct cancer
20/12/2018 -
Grant of Warrants
20/12/2018 -
Novartis announces new CEO of Oncology Business Unit
20/12/2018 -
MannKind Announces Pricing of $40 Million Public Offering
20/12/2018 -
ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions
19/12/2018 -
GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference
19/12/2018 -
DBV Technologies: DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age
19/12/2018 -
DBV Technologies : Nouvelles informations concernant Viaskin Peanut pour le traitement des enfants âgés de 4 à 11 ans
19/12/2018 -
Inspire Medical Systems, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018 -
FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
19/12/2018
Pages